Quoin Pharmaceuticals, Ltd. (QNRX) — 10-Q Filings
All 10-Q filings from Quoin Pharmaceuticals, Ltd.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
- 10-Q Filing — May 7, 2026
-
Quoin Pharma's Losses Widen Amid Soaring R&D Costs
— Nov 6, 2025 Risk: high
Quoin Pharmaceuticals, Ltd. (QNRX) reported a significant increase in net losses and operating expenses for the nine months ended September 30, 2025. The compan -
Quoin Narrows Q2 Loss Amidst R&D Spend Reduction
— Aug 7, 2025 Risk: high
Quoin Pharmaceuticals, Ltd. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company experien -
Quoin Pharma Files 10-Q for Q1 2025
— May 13, 2025 Risk: medium
Quoin Pharmaceuticals, Ltd. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Lt -
Quoin Pharmaceuticals Files Q3 2024 10-Q
— Nov 8, 2024 Risk: medium
Quoin Pharmaceuticals, Ltd. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biome -
Quoin Pharma Files 10-Q Amid Warrant Activity
— Aug 8, 2024 Risk: medium
Quoin Pharmaceuticals, Ltd. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd -
Quoin Pharmaceuticals Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
Quoin Pharmaceuticals, Ltd. (QNRX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Quoin Pharmaceuticals, Ltd. filed a 10-Q report for the period e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX